On Feb 10, 2022 Ucello Therapeutics closed a Series A round and raised $25,000,000 from Chengdu Tianfu International Bio-Town Investment & Development, Cowin Venture, Elikon […]
Seed Round – Celeris Therapeutics
On Feb 10, 2022 Celeris Therapeutics closed a Seed round and raised €3,000,000 from i&i Prague, Longevitytech.fund, Pace Ventures Enigma, R42 Group, featuring lead investors […]
Series B – Arkuda Therapeutics
On Feb 10, 2022 Arkuda Therapeutics closed a Series B round and raised $64,000,000 from Atlas Venture, Cormorant Asset Management, Eli Lilly, Mission BioCapital, Pfizer […]
Series B – Arkuda Therapeutics
On Feb 10, 2022 Arkuda Therapeutics closed a Series B round and raised $64,000,000 from Atlas Venture, Cormorant Asset Management, Eli Lilly, Mission BioCapital, Pfizer […]
Doctor Hoy’s acquired by Foundation Wellness
Feb 7, 2022 Foundation Wellness has entered into an agreement to acquire Doctor Hoy’s . Foundation Wellness based at Wadsworth, Ohio, United States. “Constantly evolving, […]
Series B – Koya Medical
On Feb 3, 2022 Koya Medical closed a Series B round and raised $26,000,000 from 3×5 Partners, Arboretum Ventures, Asahi Kasei Corporate Venture Capital, Cadence […]
Series B – Koya Medical
On Feb 3, 2022 Koya Medical closed a Series B round and raised $26,000,000 from 3×5 Partners, Arboretum Ventures, Asahi Kasei Corporate Venture Capital, Cadence […]
Post-IPO Debt – IntelGenX
On Feb 1, 2022 IntelGenX closed a Post-IPO Debt round and raised $3,000,000 from ATAI Life Sciences, featuring lead investors ATAI Life Sciences. About the […]
Everwell Specialty Pharmacy acquired by Revelation Pharma
Jan 27, 2022 Revelation Pharma has entered into an agreement to acquire Everwell Specialty Pharmacy . Revelation Pharma based at Castle Rock, Colorado, United States. […]
Series B – Simcha Therapeutics
On Jan 27, 2022 Simcha Therapeutics closed a Series B round and raised $40,000,000 from ArrowMark Partners, BVF Partners, Logos Capital, Rock Springs Capital, Samsara […]
